90 related articles for article (PubMed ID: 18252695)
1. Recombinant antibodies for delivery of antigen: a single loop between beta-strands in the constant region can accommodate long, complex and tandem T cell epitopes.
Tunheim G; Schjetne KW; Rasmussen IB; Sollid LM; Sandlie I; Bogen B
Int Immunol; 2008 Mar; 20(3):295-306. PubMed ID: 18252695
[TBL] [Abstract][Full Text] [Related]
2. Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes.
Tunheim G; Schjetne KW; Fredriksen AB; Sandlie I; Bogen B
J Leukoc Biol; 2005 Mar; 77(3):303-10. PubMed ID: 15576418
[TBL] [Abstract][Full Text] [Related]
3. CD40/APC-specific antibodies with three T-cell epitopes loaded in the constant domains induce CD4+ T-cell responses.
Rasmussen IB; Oynebråten I; Høydahl LS; Flobakk M; Lunde E; Michaelsen TE; Bogen B; Sandlie I
Protein Eng Des Sel; 2012 Mar; 25(3):89-96. PubMed ID: 22233931
[TBL] [Abstract][Full Text] [Related]
4. The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination.
Rasmussen IB; Lunde E; Michaelsen TE; Bogen B; Sandlie I
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10296-301. PubMed ID: 11517321
[TBL] [Abstract][Full Text] [Related]
5. Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells.
Lunde E; Munthe LA; Vabø A; Sandlie I; Bogen B
Nat Biotechnol; 1999 Jul; 17(7):670-5. PubMed ID: 10404160
[TBL] [Abstract][Full Text] [Related]
6. The major horse allergen Equ c 1 contains one immunodominant region of T cell epitopes.
Immonen A; Kinnunen T; Sirven P; Taivainen A; Houitte D; Peräsaari J; Närvänen A; Saarelainen S; Rytkönen-Nissinen M; Maillere B; Virtanen T
Clin Exp Allergy; 2007 Jun; 37(6):939-47. PubMed ID: 17517108
[TBL] [Abstract][Full Text] [Related]
7. Processing of an antigenic sequence from IgG constant domains for presentation by MHC class II.
Flobakk M; Rasmussen IB; Lunde E; Frigstad T; Berntzen G; Michaelsen TE; Bogen B; Sandlie I
J Immunol; 2008 Nov; 181(10):7062-72. PubMed ID: 18981126
[TBL] [Abstract][Full Text] [Related]
8. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
Durántez M; López-Vázquez AB; de Cerio AL; Huarte E; Casares N; Prieto J; Borrás-Cuesta F; Lasarte JJ; Sarobe P
Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076
[TBL] [Abstract][Full Text] [Related]
9. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
10. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.
Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G
Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules.
Bergseng E; Sidney J; Sette A; Sollid LM
Hum Immunol; 2008 Feb; 69(2):94-100. PubMed ID: 18361933
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
[TBL] [Abstract][Full Text] [Related]
13. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
14. Suboptimal recognition of a T cell epitope of the major dog allergen Can f 1 by human T cells.
Juntunen R; Liukko A; Taivainen A; Närvänen A; Durand G; Kauppinen A; Nieminen A; Rytkönen-Nissinen M; Saarelainen S; Maillère B; Virtanen T; Kinnunen T
Mol Immunol; 2009 Oct; 46(16):3320-7. PubMed ID: 19700193
[TBL] [Abstract][Full Text] [Related]
15. Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis.
Iwanami K; Matsumoto I; Tanaka Y; Inoue A; Goto D; Ito S; Tsutsumi A; Sumida T
Arthritis Res Ther; 2008; 10(6):R130. PubMed ID: 18992137
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of T-cell epitopes using the IFN-gamma ELISPOT assay.
Wulf M; Hoehn P; Trinder P
Methods Mol Biol; 2009; 524():439-46. PubMed ID: 19377964
[TBL] [Abstract][Full Text] [Related]
17. HLA class II DP epitopes.
Deng CT; Cai J; Ozawa M; El-Awar N
Clin Transpl; 2007; ():195-202. PubMed ID: 18637470
[TBL] [Abstract][Full Text] [Related]
18. Assessing vaccine potency using TCRmimic antibodies.
Neethling FA; Ramakrishna V; Keler T; Buchli R; Woodburn T; Weidanz JA
Vaccine; 2008 Jun; 26(25):3092-102. PubMed ID: 18353510
[TBL] [Abstract][Full Text] [Related]
19. Recombinant immunoglobulin-based epitope delivery: a novel class of autoimmune regulators.
Phillips WJ; Smith DJ; Bona CA; Bot A; Zaghouani H
Int Rev Immunol; 2005; 24(5-6):501-17. PubMed ID: 16318992
[TBL] [Abstract][Full Text] [Related]
20. Clinical validation of the "in silico" prediction of immunogenicity of a human recombinant therapeutic protein.
Koren E; De Groot AS; Jawa V; Beck KD; Boone T; Rivera D; Li L; Mytych D; Koscec M; Weeraratne D; Swanson S; Martin W
Clin Immunol; 2007 Jul; 124(1):26-32. PubMed ID: 17490912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
